| Oct 4, 2022 |
Oct 5, 2022 |
Outlook Therapeutics, Inc.
|
Director |
Buy |
95.0
|
+111,203
|
30.73%
|
✗
|
$142.5K |
| Sep 29, 2022 |
Oct 3, 2022 |
Outlook Therapeutics, Inc.
|
Director |
Buy |
95.0
|
+88,797
|
32.51%
|
✗
|
$110.5K |
| Mar 1, 2022 |
Mar 3, 2022 |
Outlook Therapeutics, Inc.
|
Director |
Buy |
91.3
|
+27,708
|
11.29%
|
✗
|
$46.8K |
| Feb 24, 2022 |
Feb 28, 2022 |
Outlook Therapeutics, Inc.
|
Director |
Buy |
95.0
|
+47,160
|
23.79%
|
✗
|
$69.7K |
| Feb 22, 2022 |
Feb 23, 2022 |
Outlook Therapeutics, Inc.
|
Director |
Buy |
97.5
|
+175,132
|
757.59%
|
✗
|
$257K |
| Feb 4, 2019 |
Feb 6, 2019 |
Outlook Therapeutics, Inc.
|
Director |
Buy |
82.5
|
+5,983
|
3.34%
|
✗
|
$4.8K |
| Jan 30, 2019 |
Feb 1, 2019 |
Outlook Therapeutics, Inc.
|
Director |
Buy |
91.3
|
+19,390
|
12.15%
|
✗
|
$14.6K |
| Jan 25, 2019 |
Jan 29, 2019 |
Outlook Therapeutics, Inc.
|
Director |
Buy |
91.3
|
+32,112
|
25.19%
|
✗
|
$22.7K |
| Jan 22, 2019 |
Jan 24, 2019 |
Outlook Therapeutics, Inc.
|
Director |
Buy |
90.0
|
+13,015
|
11.37%
|
✗
|
$8.8K |
| Jan 16, 2019 |
Jan 18, 2019 |
Outlook Therapeutics, Inc.
|
Director |
Buy |
82.5
|
+3,100
|
2.78%
|
✗
|
$2.1K |
| Jan 14, 2019 |
Jan 16, 2019 |
Outlook Therapeutics, Inc.
|
Director |
Buy |
85.0
|
+6,665
|
6.37%
|
✗
|
$4.7K |
| Jan 9, 2019 |
Jan 11, 2019 |
Outlook Therapeutics, Inc.
|
Director |
Buy |
85.0
|
+8,845
|
9.23%
|
✗
|
$6.3K |
| Jan 4, 2019 |
Jan 8, 2019 |
Outlook Therapeutics, Inc.
|
Director |
Buy |
91.3
|
+17,781
|
22.78%
|
✗
|
$11.1K |
| Dec 31, 2018 |
Jan 3, 2019 |
Outlook Therapeutics, Inc.
|
Director |
Buy |
91.3
|
+17,189
|
28.24%
|
✗
|
$10.1K |
| Dec 26, 2018 |
Dec 28, 2018 |
Outlook Therapeutics, Inc.
|
Director |
Buy |
90.0
|
+18,354
|
43.17%
|
✗
|
$9.7K |
| Dec 21, 2018 |
Dec 26, 2018 |
Outlook Therapeutics, Inc.
|
Director |
Buy |
90.0
|
+4,713
|
12.47%
|
✗
|
$3.1K |